{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:55:50Z","timestamp":1792101350471,"version":"4.4.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018755","name":"DLR Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002946","name":"Deutsches Zentrum fur Luft- und Raumfahrt DLR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"BMFTR Bonn","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003484","name":"Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005971","name":"Deutsche Herzstiftung eV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"German Federal Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.pharmthera.2026.109083","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:58:16Z","timestamp":1784530696000},"page":"109083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations"],"prefix":"10.1016","volume":"286","author":[{"given":"Rojda","family":"Ipek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Neuenschwander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian","family":"Marjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grandoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Schlesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0005","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/01.CIR.0000142047.28024.F2","article-title":"Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: The VALsartan in acute myocardial iNfarcTion (VALIANT) trial","volume":"110","author":"Aguilar","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/dc22-1219","article-title":"Multicenter randomized trial of intermittently scanned continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes and recent-onset acute myocardial infarction: Results of the LIBERATES trial","volume":"46","author":"Ajjan","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.803092","article-title":"Temporal trends in outcomes of ST-elevation myocardial infarction patients with heart failure and diabetes","volume":"13","author":"Ali","year":"2022","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1303685","article-title":"Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: A systematic review and meta-analysis","volume":"11","author":"Alkatiri","year":"2024","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318774","article-title":"Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission","volume":"20","author":"Almutairi","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diabres.2016.09.002","article-title":"Comparison of cardiovascular and metabolic outcomes in people with type 2 diabetes on insulin versus non-insulin glucose-lowering therapies (GLTs): A systematic review and meta-analysis of clinical trials","volume":"121","author":"Anyanwagu","year":"2016","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2014.07.010","article-title":"Temporal trends in all-cause mortality of smokers versus non-smokers hospitalized with ST-segment elevation myocardial infarction","volume":"176","author":"Arbel","year":"2014","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0040","article-title":"Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: A prospective cohort study in Sweden","author":"Asplund","year":"2025","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01655-w","article-title":"Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction","volume":"21","author":"Baviera","year":"2022","journal-title":"Cardiovascular Diabetology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109083_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005968","article-title":"Delayed care and mortality among women and men with myocardial infarction","volume":"6","author":"Bugiardini","year":"2017","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijcard.2020.08.021","article-title":"Cardiac mortality, diabetes mellitus, and multivessel disease in ST elevation myocardial infarction","volume":"323","author":"Burgess","year":"2021","journal-title":"International Journal of Cardiology"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109083_bb0065","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction","volume":"390","author":"Butler","year":"2024","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0070","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ehjacc\/zuad107","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"13","author":"Byrne","year":"2024","journal-title":"European Heart Journal Acute Cardiovascular Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa2415879","article-title":"Global effect of cardiovascular risk factors on lifetime estimates","volume":"393","author":"C, M., J","year":"2025","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2026.109083_bib587","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcag012","article-title":"The paradox of SMURF-less outcomes and its implication for diabetes","author":"Cenko","year":"2026","journal-title":"European Heart Journal - Quality of Care and Clinical Outcomes"},{"issue":"24","key":"10.1016\/j.pharmthera.2026.109083_bb0080","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/hrt.2010.197673","article-title":"Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction","volume":"96","author":"Claessen","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112092","article-title":"Association of quality of care and long-term mortality risk for individuals presenting with ST-segment myocardial infarction (STEMI) by diabetes mellitus status: A nationwide cohort study","volume":"222","author":"Cole","year":"2025","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"10270","key":"10.1016\/j.pharmthera.2026.109083_bb0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0140-6736(20)32519-8","article-title":"Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): A modelling study of pooled datasets","volume":"397","author":"D\u2019Ascenzo","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109083_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2024.09.031","article-title":"Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry","volume":"35","author":"De Luca","year":"2025","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/HJH.0000000000003890","article-title":"Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: Insights from the international multicenter ISACS-STEMI registry","volume":"43","author":"De Luca","year":"2025","journal-title":"Journal of Hypertension"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0105","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.numecd.2020.09.005","article-title":"Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes?","volume":"31","author":"Demarchi","year":"2021","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109083_bb0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCIMAGING.112.974998","article-title":"Prognostic impact of hyperglycemia in nondiabetic and diabetic patients with ST-elevation myocardial infarction. Circulation","volume":"5","author":"Eitel","year":"2012","journal-title":"Cardiovascular Imaging"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0115","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.amjcard.2017.03.016","article-title":"Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI study)","volume":"119","author":"Ertelt","year":"2017","journal-title":"The American Journal of Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0120","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.amjcard.2017.03.016","article-title":"Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI study)","volume":"119","author":"Ertelt","year":"2017","journal-title":"The American Journal of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109083_bb0125","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.124.011259","article-title":"Predicting mortality in patients hospitalized with acute myocardial infarction: From the national cardiovascular data registry","volume":"18","author":"Faridi","year":"2025","journal-title":"Circulation. Cardiovascular Quality and Outcomes"},{"issue":"10279","key":"10.1016\/j.pharmthera.2026.109083_bb0130","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(21)00272-5","article-title":"Mortality in STEMI patients without standard modifiable risk factors: A sex-disaggregated analysis of SWEDEHEART registry data","volume":"397","author":"Figtree","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004425","article-title":"Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score","volume":"4","author":"Fox","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109083_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.26599\/1671-5411.2023.03.001","article-title":"Triglyceride glucose index predicts in-hospital mortality in patients with ST-segment elevation myocardial infarction who underwent primary angiography","volume":"20","author":"Fu","year":"2023","journal-title":"Journal of Geriatric Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0145","unstructured":"Gasior, M., Pres, D., Stasik-Pres, G., Lech, P., Gierlotka, M., Lekston, A., Hawranek, M., Tajstra, M., Kalarus, Z., & Polo\u0144ski, L. (2008). Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction? - Kardiol Pol. 2008;66(1):1-8; discussion 9-11."},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0150","first-page":"143","article-title":"Prognostic impact of diabetes mellitus on patients managed by urgent percutaneous coronary intervention","volume":"100","author":"Ghariani","year":"2022","journal-title":"La Tunisie M\u00e9dicale"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109083_bb0155","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.108.814947","article-title":"Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population-based perspective","volume":"119","author":"Goldberg","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0160","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacc.2003.09.038","article-title":"Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb\/IIIa inhibition: Lessons from the GUSTO v trial","volume":"43","author":"Gurm","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.040526","article-title":"Inpatient outcomes for patients with peripheral artery disease hospitalized for acute myocardial infarction","volume":"14","author":"Gusdorf","year":"2025","journal-title":"Journal of the American Heart Association"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0175","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2018.07.137","article-title":"Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction","volume":"272","author":"Hall","year":"2018","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-12-104","article-title":"Prognostic value of admission heart rate in patients with ST-segment elevation myocardial infarction: Role of type 2 diabetes mellitus","volume":"12","author":"Han","year":"2012","journal-title":"BMC Cardiovascular Disorders"},{"issue":"10513","key":"10.1016\/j.pharmthera.2026.109083_bb0185","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","author":"Hay","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109083_bb0195","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00125-021-05625-x","article-title":"A novel diabetes typology: Towards precision diabetology from pathogenesis to treatment","volume":"65","author":"Herder","year":"2022","journal-title":"Diabetologia"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109083_bb0200","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/CIRCULATIONAHA.124.069217","article-title":"Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: Insights from the EMPACT-MI trial","volume":"149","author":"Hernandez","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0205","author":"Higgins"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2016.10.058","article-title":"Diabetes mellitus-induced microvascular destabilization in the myocardium","volume":"69","author":"Hinkel","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109083_bb0215","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2011.07.067","article-title":"Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"109","author":"Hoebers","year":"2012","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.785657","article-title":"The hypertension paradox: Survival benefit after ST-elevation myocardial infarction in patients with history of hypertension. A prospective cohort- and risk-analysis","volume":"9","author":"Hoffmann","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109083_bb0230","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2021.02.057","article-title":"Therapeutic manipulation of myocardial metabolism: JACC state-of-the-art review","volume":"77","author":"Honka","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15420\/ecr.2017:19:3","article-title":"Neuroendocrine system regulatory mechanisms: Acute coronary syndrome and stress hyperglycaemia","volume":"13","author":"de la Hoz","year":"2018","journal-title":"European Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109083_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2217\/bmm.14.100","article-title":"Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction","volume":"9","author":"Hudzik","year":"2015","journal-title":"Biomarkers in Medicine"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-025-02745-x","article-title":"Impact of diabetes on outcomes of patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease undergoing percutaneous coronary intervention","author":"Jakob","year":"2025","journal-title":"Clinical Research in Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0250","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001479","article-title":"Prognostic significance of BMI after PCI treatment in ST-elevation myocardial infarction: A cohort study from the swedish coronary angiography and angioplasty registry","volume":"8","author":"Jamaly","year":"2021","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0255","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circulation Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109083_bb0260","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ihj.2018.01.005","article-title":"Prognostic value of hyperglycemia on-admission in diabetic versus non-diabetic patients presenting with ST-elevation myocardial infarction in Tunisia","volume":"70","author":"Jomaa","year":"2018","journal-title":"Indian Heart Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109083_bb0265","article-title":"Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: A network meta-analysis. The","volume":"10","author":"Kanie","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112411","article-title":"Cardiovascular outcomes of patients with type 2 diabetes after myocardial infarction and the impact of diabetes duration: A nationwide registry study","volume":"228","author":"Kerola","year":"2025","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0275","doi-asserted-by":"crossref","DOI":"10.1177\/1479164119883983","article-title":"Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"17","author":"Khalfallah","year":"2020","journal-title":"Diabetes & Vascular Disease Research"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109083_bb0280","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034870","article-title":"Long-term risk of cardiovascular death in patients with mildly reduced ejection fraction after acute myocardial infarction: A multicenter, prospective registry study","volume":"13","author":"Kim","year":"2024","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109083_bb0285","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2019.12.034","article-title":"Impact of hyperglycemia on long-term outcome in patients with ST-segment elevation myocardial infarction","volume":"125","author":"Kojima","year":"2020","journal-title":"The American Journal of Cardiology"},{"issue":"14","key":"10.1016\/j.pharmthera.2026.109083_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027824","article-title":"Sodium-glucose cotransporter-2 inhibitors after acute myocardial infarction in patients with type 2 diabetes: A population-based investigation","volume":"12","author":"Kwon","year":"2023","journal-title":"Journal of the American Heart Association"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109083_bb0295","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40266-019-00663-y","article-title":"Elderly patients with ST-segment elevation myocardial infarction: A patient-Centered approach","volume":"36","author":"Lattuca","year":"2019","journal-title":"Drugs & Aging"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109083_bb0300","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2459\/JCM.0000000000000062","article-title":"Glycated haemoglobin and long-term mortality in patients with ST elevation myocardial infarction","volume":"16","author":"Lazzeri","year":"2015","journal-title":"Journal of Cardiovascular Medicine (Hagerstown, Md.)"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109083_bb0305","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00592-011-0343-4","article-title":"The prognostic role of in-hospital peak glycemia in stemi patients with and without diabetes","volume":"49","author":"Lazzeri","year":"2012","journal-title":"Acta Diabetologica"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109083_bb0310","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jdiacomp.2014.05.002","article-title":"Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction","volume":"28","author":"Lekston","year":"2014","journal-title":"Journal of Diabetes and its Complications"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0315","article-title":"Stress induced hyperglycemia in the context of acute coronary syndrome: Definitions, interventions, and underlying mechanisms","volume":"8","author":"Li","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01881-w","article-title":"Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: A prospective cohort study","volume":"22","author":"Li","year":"2023","journal-title":"Cardiovascular Diabetology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.numecd.2022.09.011","article-title":"The interaction between hyperuricemia and low-density lipoprotein cholesterol increases the risk of 1-year post-discharge all-cause mortality in ST-segment elevation myocardial infarction patients","volume":"33","author":"Liang","year":"2023","journal-title":"Nutrition, Metabolism, and Cardiovascular Diseases: NMCD"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0330","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in type 2 diabetic patients receiving insulin versus non-insulin treatment intensification","volume":"15","author":"Lin","year":"2025","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109083_bb0340","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0345","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/dc17-1732","article-title":"Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: A prospective study","volume":"41","author":"Marenzi","year":"2018","journal-title":"Diabetes Care"},{"issue":"39","key":"10.1016\/j.pharmthera.2026.109083_bb0350","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"European Heart Journal"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109083_bb0355","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0360","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-02056-3","article-title":"Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, the kidney, and the peripheral nerves","volume":"22","author":"Mauricio","year":"2023","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0365","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.carrev.2021.08.003","article-title":"Diabetic patients who present with ST-elevation myocardial infarction","volume":"38","author":"Megaly","year":"2022","journal-title":"Cardiovascular Revascularization Medicine\u00a0: Including Molecular Interventions"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-13032-0","article-title":"The different effects of admission blood glucose levels on the outcomes of ST elevation myocardial infarction patients with and without diabetes","volume":"15","author":"Mesri Alamdari","year":"2025","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1175731","article-title":"Type 2 diabetes and in-hospital sudden cardiac arrest in ST-elevation myocardial infarction in the US","volume":"10","author":"Mhaimeed","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0380","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02403-y","article-title":"An observational study of therapeutic procedures and in-hospital outcomes among patients admitted for acute myocardial infarction in Spain, 2016-2022: The role of diabetes mellitus","volume":"23","author":"de Miguel-Yanes","year":"2024","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0385","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/5584_2020_481","article-title":"Diabetes mellitus and acute myocardial infarction: Impact on short and long-term mortality","volume":"1307","author":"Milazzo","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109083_bb0390","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109083_bib588","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tcm.2025.06.005","article-title":"Acute myocardial infarction in patients without standard modifiable risk factors \u2013A state-of-the-art review","volume":"35","author":"Moysidis","year":"2025","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109083_bb0395","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/archinte.164.20.2273","article-title":"Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction","volume":"164","author":"Murcia","year":"2004","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bib586","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13643-026-03089-x","article-title":"Incidence of acute myocardial infarction in people with diabetes compared to those without diabetes: a systematic review","volume":"15","author":"Narres","year":"2026","journal-title":"Systematic Reviews"},{"issue":"38","key":"10.1016\/j.pharmthera.2026.109083_bb0400","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1093\/eurheartj\/ehaf390","article-title":"First myocardial infarction: Risk factors, symptoms, and medical therapy","volume":"46","author":"Nurmohamed","year":"2025","journal-title":"European Heart Journal"},{"issue":"25","key":"10.1016\/j.pharmthera.2026.109083_bb0405","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/CIRCULATIONAHA.123.065090","article-title":"Addressing cardiovascular risk in diabetes: It\u2019s more than the sugar","volume":"147","author":"Ozkan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0410","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109083_bb0415","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1016\/j.ijcard.2012.06.054","article-title":"Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The HORIZONS-AMI trial","volume":"167","author":"Planer","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109083_bb0420","first-page":"1005","article-title":"Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention","volume":"68","author":"Pres","year":"2010","journal-title":"Kardiologia Polska"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109083_bb0425","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.2337\/dc13-0394","article-title":"ST-segment elevation myocardial infarction in women with type 2 diabetes","volume":"36","author":"Radomska","year":"2013","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109083_bb0430","article-title":"Correlation between hemoglobin a1c (HbA1c) and high-sensitivity C-reactive protein (hs-CRP) in myocardial infarction patients and their six-month mortality follow-up","volume":"16","author":"Reddy","year":"2024","journal-title":"Cureus"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109083_bb0435","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2020.02.045","article-title":"Effect of smoking on outcomes of primary PCI in patients with STEMI","volume":"75","author":"Redfors","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0440","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/dom.13002","article-title":"Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction","volume":"19","author":"Reinstadler","year":"2017","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0445","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2015-2660","article-title":"Relative hyperglycemia, a marker of critical illness: Introducing the stress hyperglycemia ratio","volume":"100","author":"Roberts","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0450","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/2048872613490382","article-title":"Gender-related mortality trends among diabetic patients with ST-segment elevation myocardial infarction: Insights from a nationwide registry 1997-2010","volume":"2","author":"Roffi","year":"2013","journal-title":"European Heart Journal Acute Cardiovascular Care"},{"issue":"Supplement_2","key":"10.1016\/j.pharmthera.2026.109083_bb0455","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.1777","article-title":"Clinical practice and outcomes in elderly STEMI patients undergoing PCI with new generation DES \u2013 Data from a large worldwide registry","volume":"41","author":"Roguin","year":"2020","journal-title":"European Heart Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109083_bb0460","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ccd.25203","article-title":"Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: Results from the INFUSE-AMI study","volume":"83","author":"Sanidas","year":"2014","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109083_bb0465","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jacc.2024.04.012","article-title":"Glycemic control and coronary stent failure in patients with type 2 diabetes mellitus","volume":"84","author":"Santos-Pardo","year":"2024","journal-title":"Journal of the American College of Cardiology"},{"issue":"9733","key":"10.1016\/j.pharmthera.2026.109083_bb0470","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet (London, England)"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109083_bb0475","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2006.06.010","article-title":"Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion","volume":"98","author":"van der Schaaf","year":"2006","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0480","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf411","article-title":"Severe obesity in patients with ST-elevation myocardial infarctions: Association with age, temporal trends, and clinical outcomes","author":"Schmucker","year":"2025","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0485","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109083_bb0490","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0495","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01519-3","article-title":"Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes","volume":"21","author":"Song","year":"2022","journal-title":"Cardiovascular Diabetology"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109083_bb0500","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025885","article-title":"Impact of diabetes on 10-year outcomes following ST-segment-elevation myocardial infarction: Insights from the EXAMINATION-EXTEND trial","volume":"11","author":"Spione","year":"2022","journal-title":"Journal of the American Heart Association"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0505","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s11239-019-01812-1","article-title":"The impact of smoking on mortality after acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: A retrospective cohort outcome study at 3 years","volume":"47","author":"Steele","year":"2019","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2006.10.004","article-title":"Global registry of acute coronary events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome","volume":"153","author":"Tang","year":"2007","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2026.109083_bb0515","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amjcard.2020.10.051","article-title":"Effect of diabetes mellitus and left ventricular perfusion on frequency of development of heart failure and\/or all-cause mortality late after acute myocardial infarction","volume":"140","author":"Tomasik","year":"2021","journal-title":"The American Journal of Cardiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109083_bb0520","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034748","article-title":"Relationship between infarct artery, myocardial injury, and outcomes after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction","volume":"13","author":"de Waha","year":"2024","journal-title":"Journal of the American Heart Association"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02250-x","article-title":"Impact of acute glycemic variability on short-term outcomes in patients with ST-segment elevation myocardial infarction: A multicenter population-based study","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovascular Diabetology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109083_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/clc.20518","article-title":"Hypercholesterolemia paradox in relation to mortality in acute coronary syndrome","volume":"32","author":"Wang","year":"2009","journal-title":"Clinical Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0535","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01812-9","article-title":"Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A cohort study","volume":"22","author":"Wei","year":"2023","journal-title":"Cardiovascular Diabetology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0540","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-023-01812-9","article-title":"Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A cohort study","volume":"22","author":"Wei","year":"2023","journal-title":"Cardiovascular Diabetology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0545","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01150-0","article-title":"Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial","volume":"19","author":"Wijkman","year":"2020","journal-title":"Cardiovascular Diabetology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0550","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01479-8","article-title":"Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: Insights from a multi-center observational study","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovascular Diabetology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109083_bb0555","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/dc21-1526","article-title":"The impact of the stress hyperglycemia ratio on short-term and long-term poor prognosis in patients with acute coronary syndrome: Insight from a large cohort study in Asia","volume":"45","author":"Yang","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109083_bb0560","doi-asserted-by":"crossref","DOI":"10.1186\/cc13035","article-title":"Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock","volume":"17","author":"Yang","year":"2013","journal-title":"Critical Care (London, England)"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109083_bb0565","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/clc.23899","article-title":"Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study","volume":"45","author":"Yi","year":"2022","journal-title":"Clinical Cardiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109083_bb0570","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: A 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109083_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.105.535732","article-title":"Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction","volume":"115","author":"Zarich","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109083_bb0580","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-024-03823-z","article-title":"The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: A multicenter study","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Medicine"},{"issue":"10467","key":"10.1016\/j.pharmthera.2026.109083_bb0585","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet (London, England)"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725826001105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:28Z","timestamp":1786119328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725826001105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":120,"alternative-id":["S0163725826001105"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109083","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109083"}}